119 related articles for article (PubMed ID: 1243508)
21. [Radioimmunoassay of serum FSH, LH, estradiol-17 beta and progesterone in women with normal menstruation cycles].
Kajiwara K; Tachiyama K; Utsumiya T; Murakami T; Itonaga Y
Horumon To Rinsho; 1975 Oct; 23(10):1029-34. PubMed ID: 1238183
[No Abstract] [Full Text] [Related]
22. Complications of oral contraceptive agents--a symposium. Action and efficacy of systemic contraceptive agents, and introduction of complications.
Swerdloff RS
West J Med; 1975 Jan; 122(1):20-6. PubMed ID: 1089002
[No Abstract] [Full Text] [Related]
23. Selective inhibition by danazol of follicle stimulating hormone during the luteal phase.
Lieberman BA; Thom S; Murray MA; Jacobs HS
Br J Obstet Gynaecol; 1977 Jan; 84(1):55-7. PubMed ID: 321001
[TBL] [Abstract][Full Text] [Related]
24. Serum levels of FSH, LH, estradiol-17 beta and progesterone following the administration of a combined oral contraceptive containing 20 micrograms ethinylestradiol.
Carlström K; Lunell NO; Zador G
Gynecol Obstet Invest; 1978; 9(6):304-11. PubMed ID: 754992
[TBL] [Abstract][Full Text] [Related]
25. [Antiepileptic drugs and oral contraceptives. Preliminary note].
Meduri M; Bramanti B; Di Perri R; Volpe A; Oliva A; Baviera G
Boll Soc Ital Biol Sper; 1978 Dec; 54(23):2462-7. PubMed ID: 756744
[No Abstract] [Full Text] [Related]
26. Simultaneous radioimmunoassay of plasma FSH, LH, progesterone, 17-hydroxyprogesterone, and estradiol-17 beta during the menstrual cycle.
Abraham GE; Odell WD; Swerdloff RS; Hopper K
J Clin Endocrinol Metab; 1972 Feb; 34(2):312-8. PubMed ID: 5059762
[No Abstract] [Full Text] [Related]
27. Elevation of serum prolactin during application of oral contraceptives.
Dericks-Tan JS; Taubert HD
Contraception; 1976 Jul; 14(1):1-8. PubMed ID: 975808
[No Abstract] [Full Text] [Related]
28. Studies on the site of action of oral contraceptive steroids. II. Plasma LH and FSH levels after administration of antifertility steroids and LH-releasing hormone(LH-RH).
Schally AV; Parlow AF; Carter WH; Saito M; Bowers CY; Arimura A
Endocrinology; 1970 Mar; 86(3):530-41. PubMed ID: 4188612
[No Abstract] [Full Text] [Related]
29. Interruption of endometrial maturation without hormonal changes by an antiprogesterone during the first half of luteal phase of the menstrual cycle: a contraceptive potential.
Greene KE; Kettel LM; Yen SS
Fertil Steril; 1992 Aug; 58(2):338-43. PubMed ID: 1633899
[TBL] [Abstract][Full Text] [Related]
30. Patterns of serum LH and FSH in response to 4-hour infusions of luteinizing hormone releasing hormone in normal women during menstrual cycle, on oral contraceptives, and in postmenopausal state.
de Kretser DM; Burger HG; Dumpys R
J Clin Endocrinol Metab; 1978 Feb; 46(2):227-35. PubMed ID: 374423
[TBL] [Abstract][Full Text] [Related]
31. Serum LH,FSH, progesterone and estradiol-17beta levels of normally menstruating Indian women.
Jha P; Jain AK; Rahman SA; Dugwekar YG; Laumas KR
Indian J Med Res; 1978 Jan; 67():57-65. PubMed ID: 658997
[No Abstract] [Full Text] [Related]
32. Daily concentrations of plasma LH, FSH, estradiol, estrone and progesterone throughout the menstrual cycle.
Dhont M; VandeKerckhove D; Vermeulen A; Vandeweghe M
Eur J Obstet Gynecol Reprod Biol; 1974; 4(1 SUPPL):S153-9. PubMed ID: 4472049
[No Abstract] [Full Text] [Related]
33. Effect of daily administration of 0.5 mg. of chlormadinone acetate on plasma levels of follicle-stimulating hormone, luteinizing hormone, and progesterone during the menstrual cycle.
Saunders DM; Marcus SL; Saxena BB; Beling CG; Connell EB
Fertil Steril; 1971 May; 22(5):332-44. PubMed ID: 4102481
[TBL] [Abstract][Full Text] [Related]
34. Hormonal profile of the cycle in 68 normally menstruating women.
Landgren BM; Undén AL; Diczfalusy E
Acta Endocrinol (Copenh); 1980 May; 94(1):89-98. PubMed ID: 6770571
[No Abstract] [Full Text] [Related]
35. Immunization with hapten-coupled hCG-beta subunit and its effect on the menstrual cycle.
Pala A; Ermini M; Carenza L; Benagiano G
Contraception; 1976 Nov; 14(5):579-93. PubMed ID: 987893
[No Abstract] [Full Text] [Related]
36. Transient decline in serum progesterone levels during prostaglandin F2alpha infusion in the midluteal phase of the normal human menstrual cycle.
Coudert SP; Winter JS; Faiman C
Am J Obstet Gynecol; 1974 Jul; 119(6):755-61. PubMed ID: 4842261
[No Abstract] [Full Text] [Related]
37. Correlation between climacteric symptoms and serum levels of estradiol, progesterone, follicle-stimulating hormone, and luteinizing hormone.
Abe T; Furuhashi N; Yamaya Y; Wada Y; Hoshiai A; Suzuki M
Am J Obstet Gynecol; 1977 Sep; 129(1):65-7. PubMed ID: 900171
[TBL] [Abstract][Full Text] [Related]
38. Effect of [D-Phe2, Pro3, D-Phe6]-luteinizing hormone releasing hormone, an antagonist, on preovulatory gonadotropin secretion in the rhesus monkey.
Wilks JW; Folkers K; Humphries J; Bowers CY
Biol Reprod; 1980 Aug; 23(1):1-9. PubMed ID: 6774778
[No Abstract] [Full Text] [Related]
39. [Evolution of the pituitary gonadotropins and ovarian steroids during progestational treatment begun on the 10th day of the cycle (10 mg/day Lynestrenol)].
Dargent D; Lasne Y; Weiss A; Revel A
Gynecologie; 1978; 29(1):73-6. PubMed ID: 648699
[No Abstract] [Full Text] [Related]
40. Acute gonadotropin release induced by exogenous estradiol during the mid-follicular phase of the menstrual cycle.
Yen SS; Tsai CC
J Clin Endocrinol Metab; 1972 Feb; 34(2):298-305. PubMed ID: 5059761
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
